Sabra Healthcare REIT
SBRA

$18.64

1.53%

Market Cap: $4.37B

About: Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.

Employees: 48

Financials Real Estate Investment Trusts

0

Funds holding %

of 6,710 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

77% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $2.3M

40% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 35

4% more funds holding

Funds holding: 334 [Q1] → 348 (+14) [Q2]

8% more repeat investments, than reductions

Existing positions increased: 122 | Existing positions reduced: 113

4% more capital invested

Capital invested by funds: $3.14B [Q1] → $3.26B (+$121M) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]

0.13% less ownership

Funds ownership: 91.65% [Q1] → 91.52% (-0.13%) [Q2]

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$16

14%

downside

Avg. target

$17.75

5%

downside

High target

$20

7%

upside

4 analyst ratings

3 positive

75%

1 neutral

25%

0 negative

0%

Citigroup Nicholas Joseph 67% 1-year accuracy 4 / 6 met price target	7%upside $20	Buy Upgraded	13 Sept 2024
Truist Securities Michael Lewis 84% 1-year accuracy 37 / 44 met price target	3%downside $18	Buy Maintained	4 Sept 2024
Scotiabank Nicholas Yulico 63% 1-year accuracy 15 / 24 met price target	9%downside $17	Sector Perform Maintained	26 Aug 2024
Truist Securities Michael Lewis 84% 1-year accuracy 37 / 44 met price target	14%downside $16	Buy Maintained	27 Jun 2024

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about SBRA published over the past 30 days

Sabra Health Care REIT: Turning The Corner

Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.

Sabra Health Care REIT: Turning The Corner

10 Sweet REITs: Yield Up To 6.6%

Equity REITs, distinct from mortgage REITs, generate income from rental leases and capital appreciation, offering high yields and tax advantages by distributing 90% of taxable income. My portfolio, Rose's Income Garden (RIG), includes six of the ten highlighted REITs, chosen for their credit ratings, yields, and growth potential. Interest rates significantly impact REIT prices; current high valuations may not last, but lower rates could enhance future pricing and investment opportunities.

10 Sweet REITs: Yield Up To 6.6%

Sabra Health Care REIT, Inc. to Attend Fall Conferences

TUSTIN, Calif.--(BUSINESS WIRE)-- #Mizuho--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and other members of the company, will attend the 2024 NIC Fall Conference on September 23-25, 2024, at the Marriott Marquis in Washington, D.C. Additionally, Rick Matros, the company's Chair and Chief Execu.

Sabra Health Care REIT, Inc. to Attend Fall Conferences

Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference

TUSTIN, Calif.--(BUSINESS WIRE)-- #BAML--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.

Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference

Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Austin Wurschmidt - KeyBanc Capital Markets Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Securities John Pawlowski - Wells Fargo Rich Anderson - Wedbush Securities Michael Stroyeck - Green Street Advisors, LLC Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Christina, and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks Investment Research

Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to FFO of $0.34 per share a year ago.

Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates

Sabra Reports Second Quarter 2024 Results; Increases 2024 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)-- #2Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Beh.

Sabra Reports Second Quarter 2024 Results; Increases 2024 Guidance

Zacks Investment Research

Sabra (SBRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Sabra (SBRA) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Sabra (SBRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Sabra Publishes Fourth Annual Sustainability Report

TUSTIN, Calif.--(BUSINESS WIRE)-- #2023ESG--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today released its fourth annual Sustainability Report for the fiscal year 2023. The report showcases our programs, policies and initiatives that support our ESG priorities of environmental stewardship; diversity, equity and inclusion; human capital management; protection of health, wellness and safety of our teammates; engagement and collaboration with our operators and tenants; cybers.

Sabra Publishes Fourth Annual Sustainability Report

See News Rankings